Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis

Matilda Hamlin; Joacim Holmén; Elisabet Wentz; Harald Aiff; Lilas Ali; Steinn Steingrimsson

doi:10.2196/48843

Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis

JMIR Ment Health. 2023 Oct 11:10:e48843. doi: 10.2196/48843.

Authors

Matilda Hamlin^{1

2}, Joacim Holmén², Elisabet Wentz^{1

2}, Harald Aiff^{1

2}, Lilas Ali^{2

3}, Steinn Steingrimsson^{1

2}

Affiliations

¹ Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
² Department of Psychiatry, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
³ Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

PMID: 37819697
PMCID: PMC10600645
DOI: 10.2196/48843

Abstract

Background: Nonadherence to pharmaceutical antidepressant treatment is common among patients with depression. Digitalized follow-up (ie, self-monitoring systems through mobile apps) has been suggested as an effective adjunct to conventional antidepressant treatment to increase medical adherence, improve symptoms of depression, and reduce health care resource use.

Objective: The aim of this study was to determine patients' experience of digitalized follow-up using a mobile app as an adjunct to treatment concurrent with a new prescription, a change of antidepressant, or a dose increase.

Methods: This was a qualitative, descriptive study. Patients at 2 psychiatric outpatient clinics were recruited at the time of changing antidepressant medication. After using a mobile app (either a commercial app or a public app) for 4-6 weeks with daily registrations of active data, such as medical intake and questions concerning general mental health status, individual semistructured interviews were conducted. Recorded data were transcribed and then analyzed using content analysis.

Results: In total, 13 patients completed the study. The mean age was 35 (range 20-67) years, 8 (61.5%) were female, and all reported high digital literacy. Overall, the emerging themes indicated that the patients found the digital app to be a valuable adjunct to antidepressant treatment but with potential for improvement. Both user adherence and medical adherence were positively affected by a daily reminder and the app's ease of use. User adherence was negatively affected by the severity of depression. The positive experience of visually presented data as graphs was a key finding, which was beneficial for self-awareness, the patient-physician relationship, and user adherence. Finally, the patients had mixed reactions to the app's content and requested tailored content.

Conclusions: The patients identified several factors addressing both medical adherence and user adherence to a digital app when using it for digitalized follow-up concurrent with the critical time related to changes in antidepressant medication. The findings highlight the need for rigorous evidence-based empirical studies to generate sustainable research results.

Keywords: adherence; antidepressant; antidepressants; app; application; applications; apps; depression; depressive; digital psychiatry; dose; experience; interview; interviews; mHealth; major depressive disorder; medication; mobile app; mobile health; prescribe; prescription.

©Matilda Hamlin, Joacim Holmén, Elisabet Wentz, Harald Aiff, Lilas Ali, Steinn Steingrimsson. Originally published in JMIR Mental Health (https://mental.jmir.org), 11.10.2023.